BioVersys goes to China with antibiotic
BioVersys AG, based in the Basel Technology Park (Switzerland), has received strategic financing of 6 million US dollars (around 5.4 million euros) from the Chinese investment company Guangzhou Sino-Israel Bio-Industry Investment Fund 2 LLP (GIBF). According to the pharmaceutical company, the investment followed BioVersys’ strategic decision to expand the clinical development of its lead product … Read more